GMAB vs TEVA: stock comparison and AI forecast
Genmab A/S (GMAB) and Teva Pharmaceutical Industries Ltd (TEVA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GMAB Genmab A/S
- Price
- $56.49 +113.0% · 6M
- Market Cap
- $36.34B
- P/E Ratio
- 2.3x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
TEVA Teva Pharmaceutical Industries Ltd
- Price
- $40.70 +15.1% · 6M
- Market Cap
- $47.43B
- P/E Ratio
- 84.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- TEVA is 1.3 times larger than GMAB by market capitalization ($47.43B against $36.34B).
- GMAB trades at 2.3 times trailing earnings, TEVA at 84.8 times.
- Over the last six months GMAB returned +113.0% and TEVA +15.1%.
- TEVA carries 4.14 times debt per unit of equity, against 1.20 times for GMAB.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GMAB | TEVA |
|---|---|---|
| Market Cap | $36.34B | $47.43B |
| P/E Ratio | 2.27x | 84.79x |
| P/B Ratio | – | 6.12x |
| EPS | $24.89 | $0.48 |
| Book Value/Share | – | $6.65 |
| Revenue/Share | $8.43 | $1.34 |
| FCF/Share | $2.84 | $1.16 |
Profitability & Margins
| Metric | GMAB | TEVA |
|---|---|---|
| ROE | – | 9.1% |
| ROA | – | 1.8% |
| ROIC | 92.3% | 6.6% |
| Gross Margin | 95.4% | -428.7% |
| Operating Margin | 29.6% | 103.0% |
| Net Margin | – | 45.4% |
| EBT Margin | 41.0% | 46.4% |
| Tax Rate | 18.9% | 1.7% |
Financial Health
| Metric | GMAB | TEVA |
|---|---|---|
| Current Ratio | 2.02x | 0.88x |
| Quick Ratio | 2.01x | 0.67x |
| D/E Ratio | 1.20x | 4.14x |
| Financial Leverage | 2.20x | 5.14x |
| Interest Coverage | – | 0.3x |
| Working Capital | $229M | -$1.89B |
Cash Flow
| Metric | GMAB | TEVA |
|---|---|---|
| Operating Cash Flow | $1.87B | $1.90B |
| Free Cash Flow | $1.83B | $1.35B |
| Capital Spending | -$46M | -$550M |
| OCF Growth YoY | -25.3% | 36.5% |
| FCF Growth YoY | 0.0% | 51.5% |
| FCF/Sales | 33.7% | 86.6% |
| CapEx/Sales | 0.8% | 35.3% |
Operational Efficiency
| Metric | GMAB | TEVA |
|---|---|---|
| Asset Turnover | 2.77x | 0.04x |
| Receivables Turnover | 32.1x | 0.5x |
| Inventory Turnover | 91.9x | 2.6x |
| Fixed Assets Turnover | 233.4x | 0.4x |
| Days Sales Outstanding | 11 days | 819 days |
| Days Inventory | 4 days | 143 days |
Income Statement
| Metric | GMAB | TEVA |
|---|---|---|
| Total Revenue | $5.43B | $1.56B |
| Operating Income | $1.61B | $1.60B |
| Net Income | – | $707M |
| R&D Expense | $2.51B | $1.49B |
| SG&A Expense | $947M | $4.46B |
| Cost of Goods Sold | $251M | $8.23B |
Dividend & Shareholder Information
| Metric | GMAB | TEVA |
|---|---|---|
| Shares Outstanding | 643M | 1165M |
| EPS Growth | -17.6% | – |
GMAB vs TEVA: stock comparison and AI forecast
Which is bigger, GMAB or TEVA?
TEVA is 1.3 times larger than GMAB by market capitalization ($47.43B against $36.34B).
Which is cheaper on earnings, GMAB or TEVA?
GMAB trades at 2.3 times trailing earnings, TEVA at 84.8 times.
Which stock performed better over the last six months, GMAB or TEVA?
Over the last six months GMAB returned +113.0% and TEVA +15.1%.
Which one does Intratio's AI model rank higher, GMAB or TEVA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.